CROS NT has acquired the clinical division of PM Clinical Ltd., a sister company under the PM Holding entity currently based in the UK and Italy.

The acquisition expands CROS NT’s service offerings by adding regulatory consultancy, study design, feasibility, clinical project management and monitoring. CROS NT, previously a biometrics-focused CRO will now provide data expertise combined with clinical services to offer a full service approach.

Andrew MacGarvey, chief executive officer of CROS NT said, “This was a strategic business decision to combine its long standing expertise in clinical data services with PM Clinical’s extensive experience in clinical operations to offer our growing, global customer base a full range of services. Our clients can now rely on one provider, with expertise, flexibility and attention to detail and quality, for full product or device development.”